Safe Cosmetics Act sponsor list grows
This article was originally published in The Rose Sheet
Executive Summary
H.R. 5786, introduced July 20 by Rep. Jan Schakowsky, D-Ill., and co-sponsored by Rep. Ed Markey, D-Mass., and Rep. Tammy Baldwin, D-Wis., has garnered additional congressional support. Rep. Barney Frank, D-Mass., Rep. James Moran, D-Va., Rep. Barbara Lee, D-Calif., Rep. John Conyers, D-Mich., Rep. Alcee Hastings, D-Fla., and Rep. Diana DeGette, D-Colo., have signed on as co-sponsors. The bill, which would overhaul regulation of the personal-care industry, has been referred to the Committee on Energy and Commerce and the Committee on Education and Labor (1"The Rose Sheet" July 26, 2010)
You may also be interested in...
House's "Safe Cosmetics Act" Seeks End To Industry "Free Reign"
Dubbed the "Safe Cosmetics Act of 2010," a bill introduced last week would dramatically overhaul personal-care regulation, requiring companies that manufacture, package or distribute cosmetics for use in the U.S. to register with FDA and provide the agency with a wealth of information about their product formulations and business practices
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.